Hygienists at the Rwampara Ebola Treatment Center (CTE) put on their personal protective equipment (PPE) in the isolation area before entering the centre, May 29, 2026.

BUNIA, Democratic Republic of Congo – Victorine Ngwobu Kasemi is the director of nursing at the Evangelical Medical Centre in Bunia, the epicentre of the Democratic Republic of Congo’s record-breaking Ebola epidemic. In recent weeks she’s had to watch colleagues succumb to the virus, and her children isolate themselves from her to keep safe.

“I’m afraid that at any moment I could die or infect my children, because this is a disease we can’t control, and no one knows where or when I might get contaminated,” said Kasemi.

Like hundreds of nurses working on the frontline, Kasemi faces the challenge of providing life-saving supportive care to patients without being infected. The most painful experience, she said, is watching helplessly as her colleagues succumb to the virus.

“There was a woman who came in with a miscarriage, and she had Ebola; two doctors and several nurses who treated this patient were infected,” she said. “One doctor, unfortunately, died from the toll it took. When a nurse was declared positive, she couldn’t bear it and fell into a depression until we lost her. We were unable to save her.”

These cascading infections illustrate a well-documented mode of transmission: Ebola, a severe viral hemorrhagic fever, spreads through direct contact with the blood, vomit, or other bodily fluids of an infected person, or via contaminated equipment – that puts healthcare workers at high risk. The average fatality rate is about 50%.

At home, medical staff have to carry the added burden of protecting their families.

“When I come home, my children ask me to stay on the balcony. They prepare my shower, I leave the balcony to go shower, and my clothes are immediately soaked in water,” Kasemi said. “That’s the life I’ve lived up until now.”

Unpaid wages, anger and infection risks 

At the Ebola Treatment Centre (CTE) in Ituri province, eastern DRC, Ebola response workers protest against delayed payment, July 13, 2026.

In mid-July, the severely underfunded frontline response was thrown deeper into chaos. Dozens of medical workers at Rwampara General Hospital in Ituri, a northeastern province on the border with Uganda where the first case was detected, on strike to protest unpaid wages.

Health workers from epidemiologists to health investigators and gravediggers leading the strike said they had not received pay since the epidemic began. The strike included everyone from epidemiologists and health investigators to gravediggers.

It has been a stop-cycle of strikes since protests began. Health staff walk out, receive new promises of payment, return to work, then resume strikes when the promised money doesn’t materialise.

Visits from top country officials have done little to quell the frustration. Prime Minister Judith Suminwa visited Ituri on July 24 to reassure health staff – they were back on strike within a day, still owed months of pay.

In a separate visit to Ituri, Health Minister Roger Kamba said that the government was in the process of verifying a list of people working on the epidemic response in order to sort out payments. He said the delay was due to unrelated names being added to it.

“We must make sure these payments reach the right people,” said Kamba. “We have the means to resolve this issue.”

Uncontained spread

Hygienists at the Rwampara Ebola Treatment Center (CTE) put on their personal protective equipment (PPE) in the isolation area before entering the center, May 29, 2026.

The DRC’s current outbreak – its 17th Ebola epidemic since 1976 – is spreading faster than any on record globally. It is already the third-largest ever in the DRC – and is on pace to become the largest in the history of the continent.

Africa Centre for Disease Control (Africa CDC) director Dr Jean Kaseya said at a press briefing on Thursday that the current outbreak has recorded seven times more cases than at the same stage of the 2014-2016 West Africa Ebola outbreak,

The critical threshold of 1,000 cases, which signals that an epidemic is spiralling out of control, was crossed in just 40 days, a pace the Africa CDC described as the “fastest-growing” epidemic ever recorded.  The 2,000-day threshold was crossed in only 20 days.

it took 235 days to reach 1000 cases during the 2018 North Kivu epidemic, which until recently, was at the time was the DRC’s worst outbreak on record.

The country has recorded 3,442 confirmed cases and 1,521 deaths – a case fatality rate of 44% – as of July 28, according to the DRC Ministry of Communications and Media. Nearly 800 patients remain in isolation or hospitals.

The toll includes 112 infected health workers – 35 of whom have died – across five provinces in eastern DRC: Haut-Uele, Ituri, North Kivu, South Kivu, and Tshopo.

Contact list far behind the curve

Test positity remains over 40%, indicating ongoing intense community transmission and gaps in active case search in the community, Africa CDC said Thursday.

As the response crumbles and contact tracers struggle to track the spread, the epidemic continues to break containment efforts, outpacing the response at every turn.

Over 80% of new cases in Ituri, the epicentre of the outbreak, are not linked to known cases, according to Africa CDC. Over 60% of deaths are linked to communities instead of treatment centres, showing authorities still have major ground to cover to catch up with the speed of the outbreak.

Struggles in contact tracing are compounded by the lack of medical countermeasures. Unlike previous epidemics in the DRC, caused by the Zaire strain for which vaccines exist, this one is caused by the Bundibugyo strain, which remains without a vaccine or approved treatment — making tracing one of the only tools responders have to get ahead of the virus.

The disease often begins abruptly with fever, extreme fatigue, muscle pain, headaches, and sore throat, before progressing to vomiting, diarrhoea, skin rash, and, in the most severe cases, internal and external bleeding, according to the World Health Organization (WHO).

The incubation period lasts 2 to 21 days, and an infected person becomes contagious only after symptoms appear. Close contact with a sick person, particularly during care or funeral rites, is the main route of transmission.

‘Heroes’ on the frontline

Medical staff prepare to enter the Centre Médical Évangélique to treat Ebola patients.

Dr Mubarack Kano, Medical Director of the Ituri Neuropsychopathology Centre in Bunia, said those risking it all to contain the virus are “heroes.”

Kano, who leads Ebola investigation in Bunia’s CNK Sayo health area, said this is especially true as they face backlash from community members who want to maintain traditional funeral customs like washing, dressing, and even kissing deceased victims that are still carrying massive viral loads.

“The workers responsible for breaking the chain of transmission by organising safe and dignified burials are the most exposed people, in a community that struggles to accept giving up customary funeral rites,” said Kano.

As medical workers and authorities refuse to hand over highly contagious bodies, it is only sowing deeper mistrust among some community members, who see it as part of a cover-up and even doubt the virus’s existence and see it as part of a resource grab.

Bahati Jhon, a father of eight, is a member of a safe and dignified burial (SDB) team in Rwampara.

“Since May 15, we’ve been doing this work. We face all kinds of risks. We’re sometimes physically attacked, threatened with death, chased,” Bahati Jhon, a father of eight and member of a safe and dignified burial (SDB) team in Rwampara, explained.

“During a burial the other day, someone in the community threw a stone at me, which unfortunately damaged one of my teeth, which I ultimately lost,” Jhon said.

It was not a one-off incident. In Rwampara, a centre was burned down on 21 May after authorities refused to return a body to its family. Elsewhere, burial teams were forced to abandon a coffin under pressure from angry residents.

Workers like Jhon keep taking on these risks, even as they go unpaid. “Since the epidemic began, we haven’t received a single franc. We don’t know what to do, as we can no longer provide for our families’ basic needs,” he said.

‘No one is coming to our aid’

Medical staff put on their personal protective equipment (PPE) before entering the Ebola Treatment Center (CTE) to care for patients at the Centre Médical Évangélique, July 9, 2026.

Despite efforts by relief teams to build trust and awareness, healthcare workers remain frequent targets of disinformation. In some cases, they’re being blamed for having invented the disease to enrich themselves.

“We are not here for the money. We face a critical situation,” Dr Kamara, a Rwampara health zone doctor, said. “There is a disease that is very real, and the goal of every healthcare worker is to treat, to save lives, and to limit the spread of the disease.”

An important part of the local response now centres on building local capacity to fight disinformation. The National Institute of Public Health is training local journalists, and MONUSCO has trained community leaders in Mambasa. DRC Authorities are also calling on community radio stations to step up awareness efforts.

The response is also being hamstrung by ongoing war. The armed conflicts in eastern DRC between Congolese forces and the Rwanda-backed AFC/M23 rebellion in North Kivu, South Kivu, and Ituri have displaced over a million people and blocked health workers’ access to affected areas, putting strain on an already fragile health system and exposing frontline workers to even more insecurity.

A patient inside one of the ETCs in Ituri, who declined to give his name, described the situation as becoming dire.

“We are shocked to see the absence of caregivers. What’s even more serious is that there are patients who arrived yesterday, and others even today, in critical condition. These patients are calling for help,” he said. “But no one is coming to our aid. We are here with no medication, no nurses.”

He said patients have had no food since last Monday morning.

Beyond the treatment centres, the war is fuelling another dark crisis for eastern DRC’s civilians. Panzi Hospital in South Kivu reported an 85% increase in newly registered survivors of sexual violence in the first half of 2026 compared to the previous year.

Sexual Violence Surges in Eastern DRC as Conflict and Ebola Overwhelm Health System

Who’s stepping up?

Continental overview of planned and disbursed funding for the Ebola outbreak and response shared by Africa CDC on Thursday.

The early weeks of the Ebola response were difficult and unbalanced, delaying the construction of Ebola treatment centres and proper patient care. Since then, funding has poured in, though not always fast enough to keep pace with the outbreak.

In June, Africa CDC and the WHO launched a joint response plan costing $518 million for the period June-November 2026.

Since then, the DRC government has already injected more than $50 million into the response. Paid in two instalments ($20 million then $30 million) by the public treasury, the funding pales in comparison to the overall national response plan budgeted at $319 million, and the continental Africa CDC/WHO plan of $518 million for June-November 2026.

In total, nations and international organisations have pledged around $1 billion to the response. Some 472$ million of that total has been distributed so far, according to Africa CDC. The agency estimates $1.4 billion will be required to fully quell the outbreak.

Among the main donors: the United States ($270 million), the United Kingdom (£20 million), the EU (€15 million), and the World Bank ($243 million). The WHO Foundation is running a campaign to raise $115 million, but so far has received less than half of that amount.

While international mobilisation remains visible, execution on the ground has struggled. Among the main donors: the United States ($270 million), the United Kingdom (£20 million), the EU (€15 million), and the World Bank ($243 million).

Questions and hope

US Support for Ebola Response is Unclear Amid Opaque Funds Disbursement and Non-Engagement with WHO

Some donor countries are channelling funds directly through NGOs, which are involved in awareness campaigns and the construction of treatment centres. But in some cases, including funds allocated by the United States, questions have also arisen around the opacity of fund recipients and how they have been used.

Criticisms have also arisen that the WHO-Africa CDC coordination effort may have diffused, rather than sharpened accountability over the management of the crisis.

John Katabuka, a doctor at the ETC of La Grâce General Referral Hospital in Bunia and deputy coordinator of the Bunia health zone, is looking at the future with caution, but not without hope.

“We need to monitor entry and exit points and rely on community-based surveillance to track every alert – contacts, suspected cases, and contacts of contacts,” he said, adding that disinformation and community resistance early in the epidemic caused delays in care and a cascading rise in deaths.

“We are not pessimistic. We believe treatment centres and their equipment can be brought up to standard, so that even expatriates who fall ill can trust the local ETC rather than being evacuated abroad.”

 This article is published in collaboration with Egab.

Image Credits: Anicet Kimonyo.

United Nations (UN) Secretary-General António Guterres warned countries that the temperature extremes will continue unless fossil fuel usage is halted.

As wildfires rage across continents, heatwaves claim thousands of lives and ocean temperatures shatter records, UN Secretary-General António Guterres warned on Friday that the climate crisis has entered “overdrive.”

“This is only a warm-up act,” he said. “El Niño is strengthening, adding fuel to a planet already on fire with scorching heat domes, apocalyptic wildfires and record hot seas.”

New forecasts from the World Meteorological Organization (WMO) show El Niño, the naturally occurring climate pattern that amplifies global temperatures and disrupts rainfall, is developing into a strong event at unprecedented speed.

The Niño 3.4 index, a key measure of Pacific warming, surged from 0.5°C in April to 1.6°C in June. Sea-surface temperatures in key monitoring regions are forecast to average nearly 3°C above normal between August and October.

The WMO projects the event will continue intensifying into November, meaning the extremes already battering communities worldwide are likely a prelude rather than a peak. Through October, nearly every land area on Earth is expected to be hotter than normal.

“Fossil fuels are fanning the flames of this crisis. Expansion must stop,” Guterres said. “More coal, oil and gas will lead to a more combustible future.”

“Unless we act, to protect people and tackle the root cause of the crisis, the dangers will become deadlier still,” he warned. “The warm-up act is over. We cannot afford to wait for the main event.”

Guterres called extreme heat “the silent killer,” warning that even that description may understate the crisis. Heat deaths are vastly undercounted worldwide, he said, with many fatalities never recorded as heat-related even when heat plays a decisive role.

“Behind all of the numbers are people,” he said. “Families trapped in unsafe homes. Workers forced to choose between their health and their income. Children unable to learn.”

El Niño continues to intensify

El Niño causes wetter than normal temperatures in some parts of the world and drier than normal in others.

El Niño and La Niña are naturally occurring phases that are characterised by above-average sea-surface temperatures in the central and eastern equatorial Pacific Ocean, and affect weather patterns globally.

The WMO had warned of a strong El Niño following a hot summer that left thousands dead in Europe alone, and now is hoping to give countries a heads-up to prepare.

“This El Niño, developing against the backdrop of unprecedented ocean heat and rising temperatures, provides governments and communities with a window of opportunity to anticipate risks and act before impacts unfold. The decisions we make today will shape the impacts we experience tomorrow,” said WMO Secretary-General Celeste Saulo.

Currently, though, countries continue to invest in fossil fuels, and pension funds also invest in such projects instead of clean technology. “The hope is that the public, who are being impacted by these extreme climate-related events, that the public will demand urgent and ambitious climate action, and action not only to protect them, but also action to address the root cause,” said a UN official as part of background comments made to the media.

Also read: As El Niño Intensifies – WMO Warns Policymakers to Brace for Escalating Impacts on Health Worldwide

Extreme heat and rainfall – a deadly combination

WMO forecasts above-average temperatures across most land areas globally. Africa, southern Europe, the Arabian Peninsula, the Indian subcontinent, eastern Asia, Central America, the Caribbean, Southern Africa, much of South America and New Zealand are expected to be worst-hit by extreme heat.

“Every city and country should have heat-health action plans, early warning systems and public health measures that reach every community in time,” Guterres said.

Wetter-than-normal conditions are expected across the Greater Horn of Africa, parts of Central Asia, Southern Europe, Western North America and Southeastern South America.

In contrast, drier-than-normal conditions are more likely over the Indian subcontinent; Southern and eastern Australia; Southern Central America and parts of the Caribbean; Northwestern South America; and Northern Europe.

“The impacts are accelerating, as we’re seeing in real time. Solutions are available, as we’ve seen over the course of the last two years since the Secretary General’s call to action was launched, but what is really missing is the political will to act at the speed and scale this moment demands,” the UN official speaking on background said.

Pointing to the recent geo-political tensions between the US and Iran, UN officials are also highlighted how clean energy can help countries be sovereign. Clean energy, supported especially by China, has helped Cuba and Pakistan rapidly deploy solar energy to tide against their serious energy crunch. This shift highlights how market forces and people’s needs can shape climate action even if political will lags.

Image Credits: UN Photo, WMO, WMO.

Dr Jason Mitchell, who heads FIJI’s HIV task team, and Mark Shaheel Lal, founder of Living Positive Fiji.

RIO DE JANEIRO – A graph showing the progression of HIV infections in Fiji resembles a cobra poised to strike. For years, the 330+ islands that make up Fiji had almost zero HIV cases, but the country’s 14-fold increase in infections over the past five years is represented by a near-vertical line rearing up over the country.

Around 12,000 people are believed to have HIV in a country of less than a million people spread over 100 or so habitable islands.

“What is driving this epidemic now is risky injecting drug use of people who currently inject methamphetamines,” said Dr Jason Mitchell, chair of Fiji’s National HIV Outbreak Cluster Response Task Force.

People share needles to inject the crystal meth, another exploding epidemic, and sometimes also deliberately share their blood after taking the drug to make it go further.

The Pacific islands – positioned between East Asia, the Americas, Australia and New Zealand – have long been a gateway for drug traffickers. But during COVID-19, the drugs were unable to move, and a domestic market for crystal meth was cultivated.

Map of Fiji

“In January 2025, we declared a national HIV outbreak, which was initially confined to the population of people who inject drugs. The epidemic is now spilling over into every other population group in the country,” Mitchell told a media briefing at the International AIDS Conference (AIDS 2026).

“UNAIDS estimates that we currently have 1.2% prevalence in people between the ages of 15 to 49, and that of course continues to increase. That’s roughly one in every 60 adults,” said Mitchell.

‘The prevalence in our antenatal population now exceeds 2% and, in 2025, one child was born with HIV every week, and we lost one child to HIV-related matters every month,” Mitchell added. 

“In a country of less than a million people, this is very significant, and perhaps for me it is the greatest crime and shame of all because this is all preventable.”

Last year, around 18% of mothers with HIV passed the virus on to their babies – the highest vertical transmission rate in the world.

Two in three of last year’s people diagnosed with HIV were aged between 20 and 34, and  94% are from the indigenous iTaukei population. Men initially outnumbered women by over 2:1, but the rates in women are increasing.

There has been a 45% increase in children aged 10 to 19 becoming infected with HIV, said Mitchell.

Communal culture drives HIV spread

Mitchell attributes the rapid spread among people who inject drugs to two things: the culture of communality in indigenous Fijians and a shortage of clean needles and syringes.

“We typically share everything,” explained Mitchell, giving the example of kava, a root used in traditional ceremonies that has an antidepressant effect. 

“The practice of consuming kava is you have one mixing bowl and one receptacle or glass that we all share. The practice of kava has spilt over into our consumption of alcohol. Anyone who has grown up in Fiji will have been introduced to this practice of one glass and one [bottle of] alcohol. You would never have your own glass.”

Similarly, with crystal meth, people pool resources to buy the drug, which they then share along with the needles and blood.

But Mark Shaheel Lal, founder of Living Positive Fiji and one of the few people to come out publicly with his HIV status, says that “a needle and syringe programme is something that really needs to be implemented, and it is not”. 

“We constantly run out of [antiretroviral] medication, which has just been introduced, and no one really knows about antiretrovirals themselves.”

Huge obstacles

An HIV awareness march in Fiji.

Mitchell concedes that Fiji is struggling: “Our 90-90-90 [global HIV] targets are 40-22-3.2,” he says. This means that, instead of 90% of people knowing their HIV status, only 40% do. Instead of 90% of those living with HIV being on treatment, only 22% are in  Fiji. Of those that are, only 3.2% have undetectable viral loads, instead of the 90% target.

Many HIV cases are being diagnosed through routine HIV testing when people donate blood.

The government has introduced pre-exposure prophylaxis (PrEP) and “we’re trying to strengthen our condom programming in a region that does not use condoms”, said Mitchell. 

However, he agrees with Lal that “what is missing from this response is the availability of a needle and syringe programme”.

“That is a central part of a harm reduction programme,” said Mitchell. “There’s a lot of will, especially from our politicians and government, but we need to introduce the systems first.”

However, Mitchell concedes that police crackdowns on pharmacies selling needles and syringes have exacerbated the situation. He also recognises that it will be hard to convince people that “the practices they have adopted from consuming kava and alcohol should not be used in the situation where you’re injecting drugs”. 

The country is also struggling with resources. Australia and New Zealand are assisting Fiji, both with resources and technical support, and India has made a significant donation of ARVs, but Mitchell says the islands need more.

Despite getting a small grant from the Global Fund, Fiji is heavily dependent on this – although it is due to transition off Global Fund money within three years.

“We need a full upscaled response,” said Mitchell, warning that the epidemic also poses a threat to other Pacific islands.

Image Credits: World Health Organization, Kerry Cullinan, Fiji Ministry of Health, Wikipedia.

Restored frozen Gavi funding secures global childhood vaccination while Gavi faces intense political pressure over preservatives.
Restored frozen Gavi funding secures global childhood vaccination, while Gavi faces intense political pressure over preservatives.

The United States has unlocked frozen Gavi funding, resolving a bitter political impasse in Washington while doubling down against the WHO. But can the alliance eliminate thimerosal, a mercury-containing preservative, from its stockpiles without leaving millions of vulnerable children unprotected?

The United States will immediately release $600 million for fiscal years 2025–2026 in frozen Gavi funding, ending a tense congressional stand-off that threatened global immunisation plans, the US announced in a joint media note by the State Department and Department of Health and Human Services (HHS). The decision follows a bipartisan campaign led by Senate Appropriations Committee Chair Susan Collins and Vice Chair Patty Murray, who urged Secretary of State Marco Rubio to restore the funds.

However, the US money comes with a strict caveat, demanding Gavi work towards transitioning away from vaccines that use thimerosal as a preservative. “The Administration believes reducing reliance on mercury-containing vaccines, where suitable alternatives are available, is a pro-vaccine, pro-innovation policy,” the statement declared. Secretary of Health and Human Services Robert F Kennedy Jr reportedly associates the preservative with autism, a claim that international scientific bodies and paediatricians have repeatedly rejected.

In a press release on Thursday, Gavi welcomed the US decision. “This investment will help us to strengthen global defences against outbreaks and pandemics and protect more children from preventable diseases,” Gavi Chief Executive Officer Sania Nishtar said.

The breakthrough strengthens Gavi’s recalibrated $10.2 billion strategic budget, keeping the alliance on track to meet its 2026–2030 mobilisation goals. According to recent Gavi board projections, the partnership has already secured $9.3 billion in qualifying resources, including $2.7 billion formally signed in donor agreements.

Gavi insists science guides portfolio decisions

The State Department said Gavi committed to work towards transitioning away from using thimerosal as a vaccine preservative to unlock the funding.

Responding to a query by Health Policy Watch, Gavi noted that transitions were already underway but had previously stalled due to financial constraints. The alliance “began supporting adoption of the hexavalent and multivalent meningococcal conjugate vaccines (MMCV) in 2023,” highlighting these newer vaccine options. However, Gavi explained that “progress has been held back due to funding challenges”.

The alliance also insisted that its medical portfolio remains anchored strictly in global science. “Gavi always has and always will be guided by the global scientific consensus,” the alliance stated. It added that any portfolio changes remain “subject to Gavi Board approval and dependent on factors including country demand, programmatic context, global manufacturing capacity and affordability”.

No scientific evidence for autism claims

The American Academy of Pediatrics (AAP) and the European Medicines Agency (EMA) have repeatedly reviewed clinical safety evidence, confirming that the preservative is safe. Expert fact-checks of the scientific evidence reiterate that “extensive research proves that thimerosal is a safe ingredient in vaccines, and it does not cause neurological problems or autism”.

While the US and Europe transitioned to single-dose, mercury-free vaccines 25 years ago, developing countries still rely on cheaper multi-dose vials, where thimerosal is used to destroy any bacteria and fungi that may enter a vial each time a new dose is drawn.

Around 14% of Gavi vaccines contain thimerosal, including the five-in-one pentavalent vaccine (Diphtheria, Pertussis, Tetanus, Hepatitis B and Haemophilus influenzae type b), the Diphtheria, Pertussis and Tetanus (DPT) vaccine, Tetanus-Reduced Diphtheria (Td), Hepatitis B, Meningococcal A Conjugate (MenA) and Pneumococcal Conjugate Vaccine (PCV).

Gavi funding fire-walled from WHO

The geopolitical fracture between Washington and the WHO leaves multilateral health partnerships in financial limbo.
The geopolitical fracture between Washington and the WHO leaves multilateral health partnerships in financial limbo.

In addition, the US placed another strict financial firewall on its restored $600 million contribution, explicitly demanding that no American taxpayer funds reach the World Health Organization (WHO) through Gavi – even though the two global health bodies collaborate closely.

“The United States also reaffirms that it will not provide US Government funding to the World Health Organization through Gavi,” said the joint State Department and HHS media note.

While Gavi accepted the funding, legally binding the alliance to the US donor restrictions, it bypassed the political blockade with a simple accounting adjustment. Gavi explained that since the WHO is a core partner, its funding “is already accounted for through existing funding” from other international donors.

“As a result, US funding will be focused on vaccine procurement, which is consistent with past practices,” Gavi confirmed.

The US boycott of WHO reflects the deep and continuing diplomatic fracture with President Donald Trump, ever since he signed an executive order to exit the global health agency in January 2025, plunging the WHO into a severe financial crisis. Although Washington declared its withdrawal complete in early 2026, the WHO refuses to recognise the departure because the US has failed to pay outstanding dues.

A query to the WHO asking for comment on the funding firewall remained unanswered.

Despite a lack of scientific evidence supporting the US administration’s safety claims, Gavi will have to navigate these political demands while striving to reach its vaccination goals so as not to leave vulnerable children behind.

See related story:

US Freezes All Funds to Gavi Over Vaccine Preservative Thimerosal

Image Credits: Nana Kofi Acquah, Felix Sassmannshausen/HPW.

Three decades of conflict have made eastern DRC the worst-affected region in the world for wartime sexual violence. New reports show the current war is no exception. / Photo: Child shelters in an unfinished structure in a displacement camp in Ituri province.

Panzi Hospital, a facility in South Kivu province in eastern Democratic Republic of the Congo (DRC), a region overrun by a civil war that has displaced millions, recorded an 85% increase in newly reported survivors of sexual violence in the first six months of 2026 compared with the same period last year, according to a report released Wednesday.

The hospital admitted 646 newly reported survivors between January and June, among them “119 women and girls who became pregnant as a result of rape, including 84 girls under the age of 18,” the report said.

South Kivu province recorded 91 suicides in the first five months of 2026, already three-quarters of the full-year total for 2025, according to Panzi’s psychiatric team.

Located in the South Kivu capital Bukavu, Panzi hospital was founded by gynaecologist Denis Mukwege, who was awarded the 2018 Nobel Peace Prize for his treatment of survivors of conflict-related sexual violence in eastern DRC. Since its founding in 1999, it has served as a last resort for survivors in a region where rape has been systematically used as a weapon of war across three decades of near-continuous conflict.

Supplies arrive at Panzi Hospital in the South Kivu capital of Bukavu.

The United Nations Children’s agency (UNICEF) estimates a child is raped there every 30 minutes, accounting for up to 45% of sexual violence victims. Thousands of children were raped in the first two months of the civil war alone, a pattern UNICEF describes as the worst outbreak of such atrocities against children in decades.

UNFPA recorded 81,388 rape cases in eastern DRC between January and September 2025, a 32% increase on the same period in 2024. An estimated 250,000 to one million women have been raped in the country’s conflicts since the 1990s, according to the Global Survivors Fund. No country has recorded more conflict-related sexual violence in the period.

The surge is unfolding in the same provinces where DRC is battling the fastest-spreading and deadliest Ebola outbreak on record, stretching a health system that armed groups and funding cuts have devastated over the past 18 months.

The country has recorded 3,360 confirmed Ebola cases and 1,487 deaths in 10 weeks since the outbreak was declared on 15 May, nearing the case total of the 2018-2020 outbreak, which lasted roughly two years.

M23’s ‘reign of terror’

WFP vehicle passing through the town of Bule in Ituri province, which has been abandoned due to the conflict.

In a separate statement last week, UN experts called for an end to what they described as a “reign of terror” by the Rwanda-backed M23 armed group, citing a growing volume of testimony from civilian victims.

“Rapes, gang rapes, violent assaults and killings of civilians are a common feature of M23’s modus operandi,” the experts said. “While these crimes are not exclusive to M23, the number of individuals affected is staggering and must end.”

M23 has established a de facto system of authority in the territory it controls, using arbitrary detention, torture including sexual torture, forced labour and forced recruitment against the civilian population, the UN experts said.

Detainees are held in unofficial sites in overcrowded and unsanitary conditions with little or no medical access. Several deaths in custody have been recorded, and release has in many cases depended on payments demanded from relatives.

“The violence is unacceptable. It must end immediately and be thoroughly investigated so that those responsible are held accountable,” they said, calling on states and the UN to help revive the ceasefire signed between the Congolese government and M23 in December 2025.

“All parties to the conflict must comply with international human rights and humanitarian law and take all means necessary to protect civilians from harm.”

Care for sexual violence ‘almost non-existent’

People shelter from the rain at a displacement camp in Ituri, July 2026.

The Panzi figures are the latest in a series of major documentation of escalating sexual violence in eastern DRC this year.

In January, Human Rights Watch and the Congolese women’s rights organisation SOFEPADI documented sexual violence by at least five non-state armed groups and by the Congolese army across Ituri, North Kivu and South Kivu – the three provinces at the epicentre of the Ebola outbreak.

Survivor support collapsed at the same moment demand rose, the report found. The United States had been the primary donor of post-exposure prophylaxis kits, which must be administered within 72 hours to prevent HIV transmission and pregnancy. After US funding was withdrawn, clinics across the three provinces faced a near-total absence of PEP kits for months, leaving survivors without access to emergency care.

In April, Médecins Sans Frontières (MSF) warned that care for survivors of sexual violence in Ituri was “almost non-existent” as fighting between the Convention for the Popular Revolution and the DRC armed forces displaced tens of thousands. Seven of 14 health centres in the Fataki health zone shut down and relocated to displacement camps.

Nearly one million people are displaced across Ituri, according to OCHA, a figure that has continued to rise amid ongoing violence and the Ebola outbreak. The broader conflict across eastern DRC has displaced over 5.35 million people, UN Human Rights Office data shows.

“Many patients no longer dare to travel to seek care,” said Sylvain Groulx, MSF head of programmes in Ituri. MSF provided more than 10,000 consultations in Fataki after deploying in February and treated roughly 30 survivors of sexual violence, a fraction of the caseload it says exists.

DRC – sadly – isn’t alone. The UN Secretary General reported that more than 90,000 cases of conflict-related sexual violence were recorded globally in 2025.

The UN verified 9,788 of them across 21 situations of concern, more than double the 2024 figure, with the highest numbers in the Central African Republic, DRC, Haiti, Somalia and South Sudan. Sexual violence has also been extensively documented in Sudan, where mass rape has accompanied the Rapid Support Forces’ campaign in Darfur.

Food delivery suffers under Ebola restrictions

Man carries supplies back to his camp in Ituri, July 2026.

The same conflict driving sexual violence is now compounding the fastest-spreading Ebola outbreak in DRC’s history. The country has recorded 3,360 confirmed cases and 1,487 deaths as of 29 July, according to its health ministry, nearing the 3,400 cases of the 2018-2020 outbreak in roughly 10 weeks rather than two years.

The outbreak, caused by the rare Bundibugyo strain, was declared on 15 May. There is no approved vaccine or treatment for it. Ituri accounts for around 90% of confirmed cases. The outbreak’s index case has not been identified, and roughly 80% of new infections are emerging from unknown chains of transmission, hampering contact tracing.

More than 100 health workers have been infected. Staff at the Elikya Ebola Treatment Centre in Bunia walked out over unpaid wages on 25 July, the second such strike at the epicentre in as many weeks, in a response already hampered by attacks on treatment centres and ongoing conflict.

The outbreak has reached five provinces, with more than 2.7 million people in those zones facing acute food insecurity, including 628,000 in emergency conditions. Measures to contain the spread, including border closures and movement restrictions, have disrupted supply routes, driving up food and fuel prices amid the shortage, the World Food Programme said Wednesday.

The agency needs $101 million for the Ebola response over the next six months.

“Ebola feeds on delay, fear and hunger,” said Carl Skau, WFP’s acting executive director. “Food assistance is frontline Ebola containment. It helps families stay home, supports safe isolation, builds trust with communities and keeps health teams moving.”

“We know what works. What we need now is the speed and resources to scale it before this outbreak outruns the response.”

Former PEPFAR chief science officer Dr Mike Reid, GNP+ co-director Florence Riako Anom and Zambia’s Dr Lloyd Mulenga.

RIO DE JANEIRO – Zambia is hopeful that it can reach an agreement with the United States to salvage funds for its HIV programme, but South Africa remains frozen out of any new US funding for its HIV programme, government officials told journalists at a media briefing at the International AIDS Conference on Wednesday.

Last December, the US Embassy in Zambia announced that the US was on the brink of reaching a Memorandum of Understanding (MOU) with Zambia to “unlock a substantial grant package of US support in exchange for collaboration in the mining sector and clear business sector reforms”.

No such agreement was reached, but word got out that the US demands for access to Zambia’s minerals had been too onerous.

However, Dr Lloyd Mulenga, Zambia’s National HIV programme coordinator, told the media briefing that the talks had resumed and he was hopeful that an MOU would be signed – but declined to elaborate on what the US had demanded which had derailed the earlier talks. 

Ghana and Zimbabwe have also been unable to accept the US terms, and modelling indicates that 75,000 Zimbabweans will contract HIV within the next year unless alternative funds are found.

Earlier in the week, acting US global AIDS co-ordinator Jeff Graham told a pre-conference briefing hosted by the US government on the America First Global Health Strategy that “there are no critical minerals mentioned in any MOU”.  However, some of the health MOUs – notably with the Democratic Republic of Congo (DRC) and Guinea – were signed alongside mineral deals. 

But Dr Mike Reid, former chief science officer for the US President’s Emergency Plan for AIDS Relief (PEPFAR) in the US Department of State, told Health Policy Watch that he had resigned “over the Zambia issue”.

Reid, who also addressed the media briefing, resigned in April and described the “sadness and disappointment” he and colleagues felt at being forced to implement decisions “that make no public health sense”.

“When life-saving health assistance, often beyond the immediate capacity of partner countries, is conditioned on unrelated commercial or strategic objectives, something essential is lost,” Reid had written in his substack shortly before resigning.

“When access to treatment or prevention becomes entangled with access to critical minerals or geopolitical positioning, the work is no longer what it claims to be.”

Reid’s resignation came after The New York Times reported on a leaked memo from the US State Department’s Africa Bureau to Secretary of State Marco Rubio, which posited: “We will only secure our priorities by demonstrating willingness to publicly take support away from Zambia on a massive scale.”

No US meeting with South Africa 

Almost eight million South Africans live with HIV and, in 2024, the country was receiving around $450 million in HIV aid from the US, both via US Agency for International Development (USAID) and the US Centers for Disease Control and Prevention (CDC).

USAID funding to South Africa and other countries stopped abruptly after President Donald Trump granted Elon Musk the authority to dismantle the agency, and CDC funding ends in March 2027.

However, while the US reached out to several countries, offering to continue supporting their HIV programmes via bilateral MOUs, it has not reached out to South Africa, the country’s Deputy Health Minister, Dr Joe Phaahla, told the briefing.

“We have not been approached with any proposed new arrangement, and indications are that we are not going to be approached,” said Phaahla.

The US Ambassador to South Africa had scheduled then cancelled a meeting with South Africa’s health minister. However, Phaahla sits alongside US officials on the board of the Global Fund and “we talk offline”, he said.

“The indications are that, because of issues outside the health sector, it’s unlikely that we are going to be approached for any discussion,” said Phaahla.

Mike Reid, GNP+ co-director Florence Riako Anom, Zambia’s Dr Lloyd Mulenga and South Africa’s Deputy Health Minister Dr Joe Phaahla

Community services first to be cut

In the days after the abrupt cuts, government officials’ priority was to secure people’s antiretroviral treatment, said Mulenga. And the easiest programmes to cut to save money were those involving community-based services.

Zambia has lost $340 million in US government support – and to safeguard key ARV services for its 1.3 million people living with HIV, it has cut male circumcision, community testing and the DREAMS centres aimed at protecting women and girls from HIV.

While South Africa had already secured its ARV supply by wholly funding it domestically, 15,000 frontline workers administering services, particularly for “key populations” most at risk of HIV, lost their jobs. Another 10,000 jobs are set to vanish when the CDC funding ends next year.

Florence Riako Anom, co-director of the Global Network of People Living with HIV (GNP+), describes waking up on 21 January 2025 – the day after Trump announced the immediate freezing of all development aid – to a world where access to ARV treatment was no longer safe or guaranteed.

Before the Trump announcement, many African PEPFAR-funded countries had developed sustainability plans to integrate HIV services into primary healthcare to be phased in over five years – but “the disruption moved all of this into a day or two”, said Anom.

“We have a lot of tools available now [to address HIV], but because of the geopolitical environment we find ourselves in, our fear right now, particularly for African communities, is that we will go back to that point where they are not easy to access,” said Anom.

She said most community activists were tired – caught between the anxieties of communities and the fight for self-preservation.

Self-management

Most specialised programmes for key populations no longer exist, yet many feel too stigmatised to go to government clinics.

To address this, GNP+ is exploring “self-care” products that are largely self-managed – such as long-acting pre-exposure prophylaxis (PrEP) and self-tests for HIV.

Zambia is exploring whether private clinics can dispense ARVs to ease clinic congestion, said Mulenga. This model has been pioneered by South Africa.

It is also seeking community-based volunteers to assist in clinics.

“It’s going to be tough, but we have to find cheaper, sustainable options,” he concluded.

Meanwhile, the International AIDS Society (IAS) has responded to an incorrect map of Africa being displayed during the US information session on its America First Global Health Strategy.

The inaccurate map of Africa shown during the US government information session.

The US map locates Mozambique in the Horn of Africa, almost diametrically opposite to its actual position on the west coast of southern Africa. Nigeria appears in Niger, while West Africa’s Côte d’Ivoire was located east Africa.

IAS president-elect Professor Kenneth Ngure of Jomo Kenyatta University in Kenya, responded to the map in a statement on Thursday: “It is disheartening that a map mislabelling African countries was displayed. African countries must be taken seriously. The African continent continues to bear the greatest burden of the HIV pandemic, and our focus must now return to advancing the HIV response.”

Earlier, the US State Department told Reuters that it takes “full responsibility for ​the confusion and misrepresentation it ​caused for attendees, including ⁠our African partners”, claiming that a staff member had made last-minute changes to the presentation.

Nine miles south of the picturesque French city of Bordeaux, firefighters are at war with a phenomenon straight out of an apocalyptic epic. Scientists call them pyrocumulonimbus, or PyroCbs. NASA calls them the “fire-breathing dragon of clouds”.

The port capital of Nouvelle-Aquitaine, normally bustling with tourists at peak season, is instead drowned in smog, so thick residents are forced to wear the N95 and FFP2 masks many hoped would be a thing of the past as the COVID-19 pandemic subsided.

A NASA satellite passing over the burning pine forests of the south-western Gironde region last Friday showed the PyroCb driving smoke into the city’s skies was visible from orbit. Until this month, these fire systems had been recorded almost exclusively in Australia and North America.

These firestorms occur when fires burn so hot they drive columns of superheated air upward into the atmosphere until it cools at higher altitudes, generating dry storm clouds which power their own winds, and shoot lightning at the blaze below, creating a deadly loop that accelerates the intensity and spread of the inferno.

Pyrocumulonimbus cloud rises over California during the 2022 Mosquito Fire.

“This is a phenomenon that has never been observed in France – it is a historic first,” regional fire chief Marc Vermeulen said on Sunday. “It’s like a thunderstorm of fire.”

“This phenomenon will likely continue to generate lightning strikes, but also cause what the literature refers to as ‘ember attacks,’” Vermeulen added, referring to fragments of burning, incandescent wood carried by the wind during megafires, triggering new ignition points far beyond the blaze.

The dense smog has prevented authorities from knowing exactly where the storm is located, or the speed at which it is travelling, forcing mass evacuations now up to 220,000 people in a region of just 1.6 million. If the fire reaches the city, nearly every person living in the region will be forced to flee the flames.

“If the fire reaches the city of Bordeaux, it means that we have to evacuate at least one million people,” Jerome Steffe, mayor of Cestas, said on Tuesday. “We have never, never seen [this] in France. It will be the fire of the century.”

Europe on fire  

The Bordeaux storms of lightning fire are part of a wider crisis setting Europe and the world ablaze, threatening homes, economies, and killing hundreds of thousands through respiratory and cardiovascular disease.

Land burned across the WHO European Region reached 2.2 million hectares last year, up from 1.4 million in 2022, a 57% rise in four years, while Portugal and Spain have each reported more than twice as many fires this year as at the same point in 2025, the UN health agency reported this week. 

“Behind these numbers are real people and communities,” said Hans Kluge, WHO’s regional director for Europe. “Wildfires destroy homes and livelihoods, force evacuations, and place enormous pressure on emergency services and health systems. Tragically, they also claim lives.”

Portugal, Italy, Greece, Spain and Germany are all fighting significant blazes, and the EU has pre-positioned the largest firefighting fleet in its history and revised its guidance for member states on preparing for wildfires.

“These are difficult hours,” Spanish Prime Minister Pedro Sánchez said at a news conference Monday from Castellón, a province on Spain’s Mediterranean coast where thousands have been forced to evacuate. “This climate emergency is exceeding every threshold and scale that scientists have long warned all of Spain and Europe about.”

Americas ablaze 

Post shared by US President Donald Trump depicting a continent-wide air filter border wall.

Nearly a thousand fires are burning across Canada in one of the most intense seasons the country has recorded, pushing smoke far enough south to place more than 120 million Americans under air quality alerts in mid-July alone.

The Canadian fires prompted US President Donald Trump to pitch an idea for a new border-spanning wall, this time built from an AI-generated air filter – dubbed the ‘MERV 16 High Efficiency Particulate Air Filter’ – to stop the “invasion of smoke” crossing his nation’s northern border. 

“The United States is being unnecessarily invaded by filthy, polluted, and unhealthy air. This is Willful Negligence, and becoming a yearly occurrence, costing the United States Billions of Dollars,” Trump said on Truth Social. “Clean Air. Clean Borders.”

In South America, Brazil is bracing for a third consecutive year of drought in the Amazon. Last year’s fire season burned 46 million hectares across the country, the second-largest series of wildfires anywhere in the 21st century. 

Climate crisis death loop 

As wildfires wreak havoc worldwide, dominating global headlines, they are set to accelerate both this year and in the long run as the ongoing El Niño – projected to peak in December and continue through 2027 – and global warming – on pace for 2.8C at current emissions levels – spike temperatures. 

Successive heatwaves, dry soils and drought have created ideal conditions for extreme fire behaviour across Spain and western Europe, the WMO said on Tuesday. The heatwave driving it is the most severe ever recorded in the region and would have been “virtually impossible” without human-caused climate change, according to the World Weather Attribution group

Warming temperatures feed into wildfires. Hotter, drier conditions turn forests into fuel; in turn, burning forests release the carbon that makes conditions hotter and drier. Fires and biomass burning fuel rising temperatures in return, releasing around 1,380 megatonnes of carbon worldwide by the end of last November, more than the United States emitted from fossil fuels across the whole of 2024.

Total area burned by wildfires globally has increased by 50% since 1970. On current emissions trajectories, UNEP projects extreme fires will increase by 14% above current levels by 2030, 30% by 2050, and 50% by the end of the century. 

Four of the five worst years for forest fires on record have come since 2020, and 2024 broke the record set the year before, according to World Resources Institute data

Count of articles indexed in PubMed as of October 15, 2025, by year that have in their title or abstract the word “smoke” and the word “health” and one of the following: wildfire, wildland fire, forest fire, bushfire, grassland fire, peat fire, boreal fire, prescribed fire, WUI fire, agricultural burn, or landscape fire.

Scientific attention has followed the smoke. Around 840 studies on wildfires and health have been indexed in PubMed since 1990, roughly three-quarters of them published since 2020.

So what do we actually know about what this smoke does to the human body? How much more dangerous is it than the polluted air billions already breathe? And what, two decades into a worsening global fire era, do we still not know?

“The health impacts extend far beyond the flames,” Kluge said. “Smoke can travel long distances, worsening heart and respiratory conditions and affecting mental health, particularly among older people, children, pregnant women and those with chronic diseases.”

Let’s take a look.

How many people are dying?

Terrifying as the image of fire-breathing lightning clouds conjured out of thin air is, it isn’t direct fire that kills millions – it’s the smoke.

By the last reliable global count in 2018, 221 deaths worldwide were recorded as directly caused by wildfires. Fourteen such deaths occurred in Spain last week, mostly foreign nationals, too late to flee the flames near the capital, Madrid.

Wildfire smoke, meanwhile, killed an estimated 154,000 people in 2024, a 36% increase from 2012, according to the Lancet Climate Countdown, setting an all-time record unlikely to stand for long as temperatures continue to rise. Deaths rose fastest in countries with low Human Development Index scores, up 46% over the same period.

While 117 countries saw increased population exposure to wildfire risks, deaths from wildfire smoke increased in only 85 of those nations, which the Lancet attributes to improved prevention, management, or reduction of available fuel for wildfires due to land-use change and deforestation. 

Around 270,000 children under the age of five die each year from landscape and wildfire smoke, UNICEF research estimates

A separate Lancet analysis counting deaths from all landscape fire smoke, including agricultural burning, controlled land-clearing fires and peat fires emitting the same toxic pollutants as wildfires, put annual deaths at 1.53 million per year in the first two decades of this century.

Canada’s record 2023 fires became the first event of their kind to be measured across two continents, quantifying for the first time the threat of what researchers term “long-range PM2.5“.

Over 354 million people across North America and Europe breathed the smoke, causing 5,400 acute deaths in North America and a further 64,300 chronic deaths across both continents. Some 22,400 of those were in Europe, where the smoke arrived thinned but settled over dense population centres.

What’s in the smoke?

Wildfire smoke is a mixture rather than a single pollutant, and what goes into it depends on what the fire burns in its path. While a fire burning through pine forests emits particulate matter, carbon monoxide, nitrogen oxides, and other organic compounds contained in the burning wood, a fire that reaches a village, town or residential area will add noxious chemicals to the mix.

Burnt vehicle batteries, wiring, insulation, paint, roofing, furniture, electronics, plastics, PFAS, heavy metals and countless chemicals blend into the fire smoke. Colorado State University toxicologists have identified at least a thousand distinct compounds in it, including formaldehyde and benzene. Many of those thousand compounds have little to no research on their health effects.

The danger of fire smoke grows as the intensity of its flames grinds its composite elements into ultrafine particles, up to 25 times finer than standard PM2.5. These smaller particles carry hydrocarbons more easily past defences like masks, as well as nose hairs and mucus designed to catch larger particles, allowing them into the bloodstream, heart, kidneys, brain and placenta. 

What are the known health effects?

The respiratory effects are settled well enough that the authors of a review of medical research into wildfire smoke published last month urge researchers to stop studying them. Smoke reliably worsens asthma and chronic obstructive pulmonary disease, filling emergency rooms and leaving lingering health effects long after the smoke has dissipated.

Current research also suggests wildfire smoke appears more dangerous than ordinary urban pollution. A Southern California study found respiratory hospitalisations rose by up to 10% per 10 micrograms of wildfire-specific particulate, against a maximum of 1.3% for the same increase from traffic and industry.

Stanford researchers put the toxicity difference at roughly tenfold, with longer and repeated exposures worsening health risks across the board. Like traditional air pollution, scientists and health experts stress there is no safe level of inhaled particles.

That increased toxicity frequently results in immediate health effects including coughing, headaches, sore throats, and brain fog. While populations such as the elderly, children, and patients with respiratory risks like asthma are the most vulnerable, even healthy adults can see such symptoms last long after the smog clears.

No temporary nuisance

Evidence of the impacts on cardiovascular disease risk is also accumulating rapidly. Yale researchers reported last week that among 65 million Medicare beneficiaries in the US, cumulative exposure was linked to more hospitalisations for ischaemic heart disease, arrhythmia, stroke and heart failure, with heart failure risk more than 20% higher at greater exposure.

“Wildfire smoke should be treated as more than a temporary respiratory nuisance,” said Harlan Krumholz, a leading expert at Yale Medical School and co-author of the study.  

“Cumulative exposure is linked to a higher risk of cardiovascular hospitalisation in older adults. Clinicians should help high-risk patients prepare for smoke events, and public health leaders should expand timely alerts, clean-air spaces, and access to effective filtration, especially for communities with fewer resources.”

A study of 25 million Medicare beneficiaries published in January found each microgram of smoke particulate in a three-year average raised stroke risk by 1.3%, nearly twice the effect of pollution from other sources, amounting to 17,226 additional strokes a year among older Americans.

 “In other words, the cardiovascular toll of wildfire smoke reaches well beyond the fire lines and well beyond the day the sky turns orange,” Kai Chen, Yale associate professor of epidemiology and co-author of the study added.

Attention deficits and pregnancy complications

Research on wildfire smoke’s effect on brain health and cognition is more in its infancy compared to respiratory and cardiovascular health, but our understanding is growing.

A study of 10,228 American adults playing a brain-training game found heavy smoke the previous day was associated with a 117-point drop in mental performance scores, with the sharpest effect in the first three hours and some impairment persisting for two days.

Mental health emergencies also rise in tandem with the smoke plumes. Analysis of 86,609 emergency department visits during California’s 2020 season found 8% more mental health presentations per 10 micrograms of wildfire smoke, 15% more for depression and 29% more for mood disorders. Children’s risk rose 35%, and Black patients were more than twice as likely to present with a mood disorder, the authors found.

Exposure to wildfire smoke during pregnancy has also been linked to adverse outcomes. One study of mid-pregnancy placentas found raised levels of a fetal immune cell associated with inflammation and impaired placental function in women who had breathed smoke, suggesting particles reaching the placenta may trigger an inflammatory response in the fetus.

Other studies have linked smoke exposure to premature births, miscarriages, and cellular damage to placentas.. Another paper released this year suggests a possible link with third trimester exposure to autism diagnoses, though the authors acknowledge the study is the first to examine such a premise.

Another especially vulnerable population to the smog is people with pre-existing kidney problems. Among 52,995 dialysis patients across 22 US states during the 2023 Canadian smoke episode, the mere presence of a plume overhead was associated with an 18% increase in same-day mortality.

A young science

A new research avenue is wildfire’s potential effects on cancer. A novel study tracking over 90,000 US adults presented in April found increased wildfire smoke exposure raised risks for multiple cancers, including blood, lung, breast, bladder and colorectal. No associations were found with other cancer types, such as ovarian or melanoma, the authors said. Its findings have not yet been peer-reviewed.

While new avenues of research into wildfire smoke are intriguing, caution is warranted with how young the evidence base is on many fronts.

In June 2024, Health Policy Watch reported on research presented to the Alzheimer’s Association International Conference linking wildfire smoke to an 18% increase in dementia risk, posing significantly greater risks to brain health than other forms of air pollution. 

That figure continues to be widely cited by media outlets to this day, despite being retracted and replaced by its own authors the following month, after a newly discovered coding error revised their estimate down to a confidence interval that cancelled out the statistical significance of their data.

Many other angles of wildfire smoke’s health effects continue to rely on just a handful of papers. Blood pressure has been examined twice worldwide, once in Montana and once among twenty hypertensive adults in Athens. Kidney disease has two studies, eczema flare-ups essentially one research group, and the cancer findings are the first of their kind. 

Further research will be required to validate the links.

A generation growing up in smoke

UNICEF, which published a technical note on wildfire smoke and children in 2024, estimates wildfire smoke particulate is up to ten times more harmful to children’s respiratory health than particulate from other sources, and most harmful to those under five.

Infants breathe more rapidly than adults and take in more air relative to their body weight. They also deposit fewer particles in the nose, so a higher proportion reaches deep into lungs that are still forming.

Particulate exposure has been linked to reduced lung function, stunted growth, and neurological and metabolic dysfunction in children. Early-life exposure to wildfire smoke specifically has been associated with immune dysregulation and lung function deficits still measurable in adolescence.

Global studies of wildfire smoke and pregnancy outcomes remain sparse, and the associations found in children and adolescents are, UNICEF notes, at a nascent stage.

But what is known already is reason for alarm. Each additional microgram of fire-derived particulate raises the risk of child mortality by 2.3%, UNICEF estimates, while each microgram of wildfire smoke across a trimester raises the odds of preterm birth by 13.2%.

What the smoke does to a child over the course of a lifetime is the question the research, picking up only two decades ago, has not yet addressed. The children growing up today as wildfires become routine rather than rare, for billions around the globe will be the involuntary subjects of a vast, unplanned experiment testing this very question.

Image Credits: UNEP, Cal Fire, Shazadul Alam.

Brazilian Health Minister Dr Alexandre Padilha

RIO DE JANEIRO – News that an antiretroviral drug injected twice a year had prevented almost all HIV infection in trials electrified the HIV sector two years ago – but access to Gilead’s lenacapavir has been slow, particularly for countries in Latin America.

Brazil, which faces significant HIV transmission in certain groups, has been routinely excluded from HIV voluntary licensing deals offered by pharmaceutical companies – particularly for long-acting pre-exposure prophylaxis (PrEP) – as it is deemed an upper-middle-income country.

Brazilian Health Minister Dr Alexandre Padilha told the International AIDS Conference (AIDS 2026) being hosted in his country that negotiations with Gilead had run aground as the company wanted a price 10 times higher than that being paid by Indonesia and Thailand.

Brazil offers PrEP as part of its free universal health coverage, and Padilha said he was not prepared to bankrupt the health system by paying a high price for lenacapavir.

“Innovation without access is injustice,” said Padilha at the conference opening on Monday night.

Instead of pursuing lenacapavir, his country has opted to use ViiV’s cabotegravir, injected every second month, to bolster its PrEP programme as the company has offered Brazil “an acceptable price”, Padilha added.

ViiV and the Medicines Patent Pool (MPP) signed a voluntary licensing agreement to enable generic manufacturers to make generic versions of long-acting cabotegravir for PrEP for 90 countries – but this excludes most Latin American countries.

ViiV’s chief medical officer, Jean van Wyk told a media briefing that his country expects the generics to be available in 2028. In the meantime, it will make two million doses of cabotegravir for LMICs at a “non-profit price”.

Eighteen countries are using it so far, with over 520,000 doses having been dispensed, Van Wyk said.

Long-acting antiretroviral medicine to prevent HIV offers the biggest global opportunity to control the virus that has long evaded a vaccine. It is particularly important to protect people who are at high risk of HIV infection.

Almost 830,000 Brazilians are living with HIV, and the virus is spreading particularly among men who have sex with men and transgender women.

Gilead under pressure over lenacapavir 

Protesters at AIDS 2026 are demanding that Gilead ensures that the countries that participated in the clinical  trial of lenacapavir get access to it at a fair price.

Last month, Médecins sans Frontières (MSF) launched a campaign to demand that the US-based Gilead “immediately make the highly effective HIV prevention medicine lenacapavir more widely available across the globe”.

The six-monthly injection is particularly important for groups most at risk of HIV, including “men who have sex with men, transgender people, sex workers, people who inject drugs, and incarcerated people, as well as those in conflict and other fragile humanitarian contexts”, said MSF.

Gilead’s senior vice president of clinical development, Dr Jared Baeten, told a media briefing on Tuesday that lenacapavir had received regulatory approval in Europe and the US a year ago – a year after the clinical trial results had been announced at the AIDS 2024 conference in Munich.

In October 2024, Gilead signed voluntary licensing deals with six generic pharmaceutical manufacturers to make and sell generic lenacapavir. The generics are expected to be ready by mid-2027.

Gilead sells lenacapavir for $28,000 a year in the US, but MSF argues that Gilead will still make a profit if it sells lenacapavir for $40 – particularly as this will enable countries to expand access far more widely.

Baeten said that the medicine was being rolled out in 10 African countries and that 600,000 people would be using lenacapavir by the end of this year. Gilead also has support from the US government to expand access to up to three million people.

PrEP is particularly important for preventing HIV in “key populations” where the virus is flourishing – including sex workers, men who have sex with men, transgender women and people who inject drugs. But the Trump administration has stopped funding most of these groups, focusing its HIV response on pregnant women and children in its HIV response.

Dr Tedros Adhanom Ghebreyesus, the World Health Organization’s (WHO) Director-General, said that the  “criminalisation of key populations” was one of the three key challenges undermining the HIV response.

“We have to fight that, and we need to repeal the laws that criminalise people for who they are or what they need to survive,” Tedros told the 7000 delegates at the opening of AIDS 2026. The other two key challenges are the withdrawal of funds and the undermining of community-led organisations who have been key to the HIV response.

Eight million South Africans excluded

The US has also decided not to support South Africa’s HIV response, including its lenacapavir rollout, despite the country having the largest HIV positive population in the world. Approximately eight million South Africans are living with HIV, almost 13% of the population.

Last month, South Africa launched its lenacapavir rollout to high-risk groups with a modest goal of reaching 30,000 people, largely supported by the Global Fund. Young women are most at risk of HIV infection in South Africa.

The Desmond Tutu Foundation’s Elzette Rousseau said there was widespread support for injectable PrEP in the communities they worked with.

A trial of 3,700 people to test the acceptance of long-acting PrEP found that three-quarters of the participants opted for injectables rather than pills. When offered the choice between monthly injectable cabotegravir and the six-monthly lenacapavir, 80% had opted for lenacapavir, said Rousseau.

Activists from Latin America have staged several protests against Gilead at the AIDS 2026 conference, pointing out that their countries were part of the clinical trial of lenacapavir and should have access to the product.

However, Baeten said that all trial participants had access to lenacapavir, and this would only stop once they could access it in their countries. He added that 120 countries would have access to the medicine once the generics came on track.

Merck takes a different approach

Merck/ MSD’s Eliav Barr.

Merck/ MSD, which is currently testing a monthly pill, alimatravir, as PrEP, has taken an innovative approach to ensure access to its yet-to-be-proven medicine.

Last week, it announced that it had granted voluntary licenses to seven generic companies – three in sub-Saharan Africa and four in India – to produce the medicine for 129 low- and middle-income countries.

“The royalty-free agreements with these companies cover both the public and private sectors and will enable supply of generic alimatravir in 129 LMICs that account for a substantial majority of new HIV diagnoses globally,” the company announced.

Once again, Latin America was excluded – until Tuesday morning, when Merck/ MSD announced that it had signed a memorandum of understanding (MOU) with the Brazilian government’s Oswaldo Cruz Foundation (Fiocruz) to ensure access to alimatravir should the trial be successful.

Fiocruz is the Brazilian government’s biomedical research and medicine production agency. 

Merck/ MSD’s Dr Eliav Barr told a media briefing on Tuesday that the two parties would start to negotiate the terms of access, adding that Fiocruz could produce alimatravir for the Latin American region.

“We are trying to reach agreements now to avoid limited supply at launch,” said Barr, head of global clinical development.

The company is also preparing regulatory submissions if alimatravir proves effective at the conclusion of its phase 3 trial in the second half of 2027.

Image Credits: Márcia Moreira / IAS..

WHO headquarters in Geneva: Unprecedented reform closes a loophole, forcing campaigning Regional Directors on leave.
WHO headquarters in Geneva: Unprecedented reform closes a loophole, forcing campaigning Regional Directors on leave.

In a first, WHO Regional Directors must take a leave of absence to run for the top job, the World Health Organization (WHO) confirmed to Health Policy Watch on Monday. This sweeping election reform closes a crucial loophole in the ongoing Director-General election process, aiming to curb shadow campaigns just as the first candidates officially enter the race. Meanwhile, Dr Jarbas Barbosa, WHO Regional Director for the Americas / Pan American Health Organization, who had been reported as a possible contender, told Health Policy Watch he is not running.

The rules of global health diplomacy have quietly shifted as the WHO Director-General Election approaches. WHO Director-General Dr Tedros Adhanom Ghebreyesus has closed a controversial governance loophole with a new directive, which will require WHO Regional Directors who enter the race to become WHO’s next Director-General to take leave on one-half of their salaries, while they campaign.

“All internal candidates will be placed on leave to ensure a clear separation between their campaign activities and WHO’s functions. For the first time this requirement applies also to elected officials, such as Regional Directors,” the WHO confirmed, responding to a query by Health Policy Watch.

New rule upends past precedent

The new directive closes loopholes, demanding strict separation between campaign activities and official WHO functions.
The new directive closes loopholes, demanding strict separation between campaign activities and official WHO functions.

A playbook of rules for the upcoming campaign, reviewed by the Executive Board in their last meeting in May, had already stated that the “Director-General intends to place internal candidates on special leave to ensure a clear separation between their campaign activities and WHO’s functions.”

However, these election guidelines had historically exempted Regional Directors because they are elected by WHO member states in their region. RD’s thus enjoyed a distinct structural advantage over any other WHO candidates because they could retain their influential platforms, high salaries and extensive institutional travel budgets, as well as full authority while quietly mounting a bid for the top job.

Other WHO staff, on the other hand, were required to take unpaid or half-paid leave to run for office, ensuring a clear separation between their campaign and their official work.

Regional Directors will face the same rules as other WHO staff

Now, however, under the new directive recently issued by Tedros, Regional Directors will face the same financial realities. They will be required to exhaust their accrued annual leave before being placed on half-paid special leave until the Executive Board nominates the finalists. To maintain operations, the Director-General will designate an officer-in-charge to replace any campaigning Regional Director.

As of now, the required leave triggers once a candidate’s name is published on the WHO website.

In the email response to Health Policy Watch, the WHO said, however, that it reserves the right to pull the trigger even earlier in some cases: “WHO reserves the right to place staff on leave before this in the interests of the Organization, for example in the event of an earlier public and official announcement of a candidacy by a member state,” the organisation explained.

Furthermore, any internal candidates not yet publicly known will be automatically disclosed as prospective candidates once their candidacies are formally accepted following the 24 September submission deadline.

The DG issued the new leave order based on the WHO “Code of Conduct” for the DG elections, last updated by the World Health Assembly in 2020. The code states: “WHO staff members, including the Director-General in office, who are proposed for the post of Director-General, are subject to the obligations contained in the WHO Constitution, Staff Regulations and Staff Rules as well as to the guidance that may be issued from time to time by the Director-General.” (Section IV)

Grey areas remain

The WHO issued a new directive introducing leave for campaigning Regional Directors for the first time.
The WHO issued a new directive introducing leave for campaigning Regional Directors for the first time.

Even so, the revised mandate leaves a procedural grey area regarding the point at which a candidate is “officially recognised” – and thus needs to step down.

Official acknowledgement, in the form of publication on the WHO website, typically occurs at the specific request of a nominating member state to WHO.

However, should a country to delay their formal nominating request, that could feasibly allow their candidate to continue high-profile diplomatic travel, maximising their institutional privileges and travel budgets to build support for their campaigns, added a source close to the election process.

“The real grey area in this connection may be about campaign activities that take place before the formal process is launched,” explained former WHO legal counsel Gian Luca Burci, responding to a query by Health Policy Watch.

However, Burci notes that WHO Code of Conduct can apply to any electoral activities, regardless of the exact timeline. Behind the scenes, sustained international travel to major donor capitals by regional leaders has already drawn scrutiny.

First contenders emerge, Barbosa rules out bid

WHO regional director Dr Hanan Balkhy reportedly entered the race.
WHO Regional Director Dr Hanan Balkhy reportedly entered the race.

The reform arrives as the formal succession race begins, with Saudi Arabia and Qatar reportedly circulating the first diplomatic notes to nominate Dr Hanan Balkhy, the current Regional Director for the Eastern Mediterranean, and former public health minister Dr Hanan Mohammed Al Kuwari, respectively.

Questions submitted by Health Policy Watch to Balkhy regarding her candidacy and when her mandated leave will commence remain unanswered as of publication time.

An enquiry sent to Dr Hans Kluge, Regional Director for Europe, regarding his potential candidacy had not yet received a response either.

One rumoured contender who will not be impacted by the new mandatory leave directive is the Director of the Pan American Health Organization (PAHO), Dr Jarbas Barbosa. “I am not running for WHO DG,” said Barbosa, responding to a query by Health Policy Watch.

While expressing that he was honoured to be listed as a potential candidate, the regional leader noted his focus is to lead PAHO through these uncertain times and advance regional health agendas, including the PAHO Elimination Initiative for 30 diseases and the Better Care for NCDs programme.

Campaigning amid institutional crisis

The tightening of campaign regulations unfolds against the backdrop of a severe financial crisis.

Due to the outstanding payments by, among others, the United States after its announcement to withdraw from the WHO, the organisation has been forced to execute massive workforce cuts to address a critical funding gap.

The organisation is shedding up to 23% of its global staff, reducing the headcount to approximately 7,283 personnel. This includes 1,275 voluntary separations and 1,232 posts abolished outright.

Even after slashing its 2026-2027 base budget proposal to roughly $4.27 billion, the core mandate still faces a 15% shortfall of $660 million. Meanwhile, the organisation’s overall budget gap is projected at $1 billion.

The contrast between this dire financial reality and potential lavish, globe-trotting campaigns has sharpened scrutiny. As the field of contenders widens before the September deadline, the true test will be enforcement.

See related story:

Want to Become the Next WHO Director-General? Get in Line 

Image Credits: Guilhem Vellut, Felix Sassmannshausen/HPW, X/Tedros Adhanom Ghebreyesus, Hannan Balkhy.

Luis Pizarro (R), newly-appointed head of Unitaid, with Dr Bernard Pécoul, founder DNDi, at a hospital in the Democratic Republic of Congo.

Luis Pizarro, Unitaid’s newly-appointed Executive Director comes to the organization with sizeable depth and breadth of experience – as the leader of Geneva’s Drugs for Neglected Diseases Initiative (DNDi) and before that, leadership of ventures in Africa, Asia and the Americas.

However, his main challenge at Unitaid will be steadying the financially troubled organization, which has raised less than half of the funds needed to sustain its annual investment budget of $300 million for 2026. And it faces a shortfall of more than $800 million in the current five-year $1.5 billion budget cycle (2023-2027).  

The crisis follows the loss of support for Unitaid’s innovative financing model, built upon the world’s first solidarity fund taxing airline tickets and certain financial transactions. The model was pioneered two decades ago by France, Unitaid’s leading donor, in the birthing of the organization in 2006. 

But the Solidarity Fund for Development was abolished last year in the wake of French legislation redirecting the airline tax revenues and fees to the general budget.  That leaves Unitaid heavily exposed to the vagaries of donor whims in annual fund-raising cycles.

Meanwhile, Unitaid’s longtime director, Philippe Duneton, who was instrumental in the foundation of the agency in 2006, is stepping down. 

Philippe Duneton, Unitaid’s outgoing director signs a collaboration agreement with Mohamed Janabi, Director of the WHO African Region, in February 2026.

First in a series of leadership changes in Geneva 

Despite the criticism of opacity around the leadership selection process, response to Pizarro’s appointment was upbeat. 

The Chilean-born and French trained medical doctor has a CV well suited to the task at hand. Prior to joining DNDi, he was the first CEO of the French-based health NGO Solthis, developing it into a leading actor in West and Central Africa through upheavals such as the 2014-2016 Ebola outbreak. Between 2020-2022, Pizarro served briefly as head of Unitaid’s HIV portfolio at the height of the COVID pandemic before taking over the helm at DNDi. 

“I have only positive things to say, I think he’ll do a great job,” one long-time Geneva health policy actor told Health Policy Watch, on condition of anonymity. “But with French funding at risk, his main job will be fundraising, I think.”

“In a sense this is the first piece of the puzzle in terms of finding new leadership for Geneva institutions,” added Thiru Balasubramanian, Geneva representative of Knowledge Ecology International (KEI), a US-based NGO focused on equitable access to medicines and vaccines.

Dr. Sania Nishtar Chief Executive Officer, Gavi, in Cairo.

“The Global Fund and WHO are still in the hunt of course, and now, DNDi.

“And perhaps Gavi will be as well,”  he said, referring to as-yet-unconfirmed reports that Gavi’s Executive Director, Sania Nishtar, might leave her current post to compete in the race for Director General of WHO.

Overlapping mandates  

One of Unitaid’s big recent achievements – a $40 annual price for injectable lenacapavir, a twice-yearly HIV prevention shot just two years after first regulatory approvals.

Unitaid was established in 2006 by France, Brazil, Chile, Norway, and the United Kingdom as a collaborative initiative hosted by the WHO. 

As Unitaid’s primary architect, France became the agency’s dominant donor, contributing more than $2 billion, which accounts for roughly 56% of the organisation’s overall funding since its inception. 

However, in light of the recent cutbacks in official development assistance by European governments, as well as the United States, critics now are questioning whether the WHO-hosted Unitaid can justify its current model, including some 110, mostly Geneva-based, employees. 

That model involves an institutional mandate and administrative system separate from Gavi, the Vaccine Alliance and The Global Fund to Fight AIDS, Tuberculosis and Malaria – while the two larger organizations serve as the platform for scaleup and rollout of the innovations that Unitaid trials and tests. 

French ‘toy’ or essential global health tool?

Speaking to Health Policy Watch earlier this month, French Minister Delegate for Foreign Affairs, in charge of international partnerships, Éléonore Caroit, affirmed that the Unitaid model remains relevant and that France would remain Unitaid’s “leading partner.”

“Unitaid has an ‘end-to-end’ mandate – identifying, coordinating, and funding the interventions that make efficient, low-cost rollout possible – which then allows the Global Fund and Gavi to take those solutions to scale”.

Unitaid’s work and that of these other bodies is therefore complementary, not duplicative, she argued.

“Merging these entities and their mandates would risk a loss of specificity and expertise, an excessive concentration of missions in one place, and ultimately, less impact for the people who need it most,” Caroit warned.

However, not everyone remains so convinced.  

One one seasoned Geneva health expert described Unitaid as a ‘French toy’ saying it is “likely to close soon.” 

https://healthpolicy-watch.news/unitaid-leadership-search/

Image Credits: @ProfJanabi , @Unitaid.